Making a difference: Molecules, mechanisms and more

Editor’s Choice: A phase II, randomized, double-blind study of the use of rucaparib vs. placebo maintenance therapy in metastatic and recurrent endometrial cancer Editor’s Choice: Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)–targeting antibody-drug conjugate (ADC), in combination with pembrolizumab in patients with platinum-resistant ovarian cancer Editorial: From one-size-fits all to biology-driven care: Emerging paradigms in gynecologic oncology Hosted by: Paola Gehrig, MD, Associate Editor of Gynecologic Oncology Featuring: Bradley Corr, University of Colorado, Aurora, CO, USA Ursula Matulonis, Dana-Farber Cancer Institute, Boston, MA, USA Mary M. Mullen, Washington University School of Medicine, St Louis, MO, USA Rebecca Arhend, University of Alabama at Birmingham, Birmingham, AL, USA Check out more content on the journal's homepage at

You can listen to Making a difference: Molecules, mechanisms and more online on Radio and Podcast. Open the player on this page to stream the available audio.

Making a difference: Molecules, mechanisms and more is an episode from Gynecologic Oncology by Health Advance.

This episode is 38:54 long.

This episode was published on Nov 17, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Gynecologic Oncology when more episodes are available from the podcast feed.